U.S. market Closed. Opens in 17 hours 13 minutes

CORT | Corcept Therapeutics Incorporated Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Revenue482.38M401.86M365.98M353.87M306.49M251.25M159.20M81.32M50.29M26.55M10.36M3.31MN/AN/A29.00K209.00K482.00K294.00KN/AN/AN/AN/AN/A
Cost of Revenue6.48M5.38M5.28M5.58M5.50M5.21M3.55M2.06M1.36M882.00K143.00K91.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit475.89M396.47M360.70M348.29M300.98M246.03M155.65M79.26M48.92M25.67M10.21M3.22MN/AN/A29.00K209.00KN/AN/AN/AN/AN/AN/AN/A
Operating Expenses368.61M283.84M236.22M220.09M189.38M156.54M102.79M69.08M52.37M53.29M51.71M39.49M32.33M27.44M20.28M19.90M12.73M25.88M21.16M16.04MN/AN/AN/A
Selling, General & Admin184.26M152.85M122.36M105.33M100.36M81.29M62.42M45.24M36.95M34.92M31.24M25.41M11.33M8.49M5.88M5.75M4.87M5.04M4.08M4.49M1.89M5.53M2.62M
Research & Development184.35M130.99M113.86M114.76M89.02M75.25M40.38M23.84M15.42M18.37M20.47M14.07M21.00M18.95M14.40M14.15M7.86M20.83M17.07M11.55M8.11M13.26M5.39M
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income107.28M112.63M124.48M128.20M111.61M89.50M52.85M10.18M-3.44M-27.62M-41.50M-36.27M-32.33M-27.44M-20.25M-19.69M-12.24M-25.58M-21.16M-16.04M-9.99M-18.80M-8.01M
Other Expenses / Income17.27M3.56M529.00K3.40M5.07M2.66M-49.00K-2.04M-2.96M-3.76M-4.51M-1.78M-25.00K-25.00K-17.00K-1.32M-16.00K-10.00K-52.00K-67.88KN/AN/AN/A
Before Tax Income124.56M116.19M125.01M131.60M116.68M92.15M52.81M8.14M-6.41M-31.38M-46.01M-38.05MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses18.42M14.77M12.49M25.59M22.50M16.74M-76.32MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income106.14M101.42M112.51M106.01M94.18M75.41M129.12M8.14M-6.41M-31.38M-46.01M-38.05M-32.35M-25.97M-20.17M-20.06M-11.57M-24.87M-20.09M-15.53M-9.81M-18.50M-7.45M
Interest ExpensesN/A3.56MN/AN/A5.07M2.66M49.00K2.04M2.96M3.76M4.51M1.78MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding103.56M106.79M115.65M115.41M114.35M115.34M113.53M110.57M106.88M100.98M99.82M93.02M83.31M68.34M52.44M46.72M34.25M22.84M22.61M18.44M8.65M6.72M5.38M
Diluted Shares Outstanding111.74M115.97M125.96M124.19M122.57M126.69M124.52M116.14M106.88M100.98M99.82M93.02M83.31M68.34M52.44M46.72M34.25M22.84M22.61M18.44M8.65M6.72M5.38M
EBITDA109.64M112.63M124.48M128.20M111.61M89.50M52.96M10.27M-3.29M-27.48M-41.42M-36.24M-32.33M-27.43M-20.16M-20.05M-11.56M-24.86M-20.45M-14.43M-9.97M-18.80M-8.01M
EBITDA Margin22.73%28.03%34.01%36.23%36.41%35.62%33.27%12.62%-6.54%-103.49%-399.94%-1,096.01%0.00%0.00%-69,503.45%-9,592.82%-2,398.34%-8,455.44%0.00%0.00%0.00%0.00%0.00%
EBIT124.56M119.75M125.01M131.60M121.75M94.81M52.85M10.18M-3.44M-27.62M-41.50M-36.27M-32.35M-25.97M-20.17M-20.06M-11.57M-24.87M-20.09M-15.53M-9.81M-18.50M-7.45M
EBIT Margin25.82%29.80%34.16%37.19%39.72%37.74%33.20%12.52%-6.85%-104.02%-400.66%-1,096.82%0.00%0.00%-69,537.93%-9,598.56%-2,401.04%-8,460.20%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙